Extensions for Using Data Elements from FHIR R5 in FHIR R4B
0.1.0 - STU
Extensions for Using Data Elements from FHIR R5 in FHIR R4B
0.1.0 - STU
Extensions for Using Data Elements from FHIR R5 in FHIR R4B - Downloaded Version null See the Directory of published versions
http://terminology.hl7.org/ValueSet/v2-0252 for use in FHIR R4BThe FHIR R5 ValueSet Hl7VSCausalityObservations has no mapping to FHIR R4B.
| Source System | Code | Display | Has XVer | Target System | Code | Display |
|---|---|---|---|---|---|---|
http://terminology.hl7.org/CodeSystem/v2-0252 |
AW |
Abatement of event after product withdrawn | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
BE |
Event recurred after product reintroduced | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
DR |
Dose response observed | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
EX |
Alternative explanations for the event available | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
IN |
Event occurred after product introduced | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
LI |
Literature reports association of product with event | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
OE |
Occurrence of event was confirmed by objective evidence | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
OT |
Other | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
PL |
Effect observed when patient receives placebo | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
SE |
Similar events in past for this patient | Yes | |||
http://terminology.hl7.org/CodeSystem/v2-0252 |
TC |
Toxic levels of product documented in blood or body fluids | Yes |
IG © 2025+ FHIR Infrastructure. Package hl7.fhir.uv.xver-r5.r4b#0.1.0 based on FHIR 4.3.0. Generated 2026-03-20
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change